Search
for
Sort by
Research 61–90 of 1000+
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- The Black identity, hair product use, and breast cancer scale
- Breast Cancer-Related Neoplastic Alopecia: A Case Report and Review of the Literature
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- ANALYSIS OF ADVERSE DRUG REACTIONS (ADRs) AND THEIR SEVERITY IN BREAST CANCER PATIENTS TREATED WITH THE DOCETAXEL-DOXORUBICIN REGIMEN AT SULTAN AGUNG ISLAMIC HOSPITAL
- Innovative sequence of docetaxel–gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I study
- The evolution of primary multimodality treatment in resectable breast cancer
- Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer
- Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer
- Pattern Alopecia during Hormonal Anticancer Therapy in Patients with Breast Cancer
- Ayurveda-Based Supportive Care Using Guduchi, Ashwagandha, and Curcumin for Breast Cancer Patients: A Pilot Observational Study on Quality of Life and Safety
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Scalp hypothermia for the prevention of chemotherapy-induced alopecia in breast cancer
- Fibroblast heterogeneity and functions: insights from single-cell sequencing in wound healing, breast cancer, ovarian cancer and melanoma
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- A discrete transition zone between cuticle and cortex layers of a human hair fibre: changes observed in the presence of breast cancer
- Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab
- Liposomes in cancer therapy
- Survey on adverse events associated with drug therapy for breast cancer patients
- Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer
- Quality of Life of Patients with Metastatic Breast Cancer Treated with Epirubicin and Docetaxel
- Finasteride Use and Risk of Male Breast Cancer: A Case–Control Study Using Individual-Level Registry Data from Denmark, Finland, and Sweden
- Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling
- Research advances of tissue-derived extracellular vesicles in cancers
- Evaluation of the Hemogram of Breast Cancer Patients Treated by Therapeutic Protocol Based on Immunohistochemical Analysis: A Retrospective Study
- Breast cancer in a transgender man
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients
- Miscellaneous Exogenous Hormones and Breast Diseases: A Matter of Concern for the Gynecologist
- Racial and Ethnic Disparities in Persistent Chemotherapy-Induced Alopecia Among Women With Breast Cancer